terfenadine has been researched along with Eczema in 2 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Eczema: A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a double blind study patients with hay fever were treated with Astemizole or Terfenadine for 3 to 4 weeks, 12 patients with Astemizole and 6 patients with Terfenadine." | 5.05 | [Hay fever therapy with 2 non-sedating antihistaminics]. ( Bäurle, G, 1985) |
| " However, fexofenadine probably leads to a small improvement in patient-assessed pruritus, with probably no significant difference in the amount of treatment used to prevent eczema flares." | 5.01 | Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema. ( Apfelbacher, CJ; Böhmer, MM; Carter, B; Jupiter, A; Matterne, U; Weisshaar, E, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matterne, U | 1 |
| Böhmer, MM | 1 |
| Weisshaar, E | 1 |
| Jupiter, A | 1 |
| Carter, B | 1 |
| Apfelbacher, CJ | 1 |
| Bäurle, G | 1 |
1 review available for terfenadine and Eczema
| Article | Year |
|---|---|
Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.
Topics: Administration, Oral; Administration, Topical; Adult; Cetirizine; Chemotherapy, Adjuvant; Child; Ecz | 2019 |
1 trial available for terfenadine and Eczema
| Article | Year |
|---|---|
[Hay fever therapy with 2 non-sedating antihistaminics].
Topics: Arousal; Astemizole; Benzhydryl Compounds; Benzimidazoles; Clinical Trials as Topic; Conjunctivitis; | 1985 |